McHale Duncan - Insider Non-Derivative Transactions at Evelo Biosciences, Inc. (EVLO) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Nov 8, 2023, McHale Duncan's relationship to Evelo Biosciences, Inc. (EVLO) is Officer (Chief Medical Officer), and currently has 16,984 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other EVLO insiders.
Data Source: SEC.
McHale Duncan - Insider Non-Derivative Transactions of EVLO Common Stock
McHale Duncan - Insider Non-Derivative Transactions at EVLO
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Nov 9, 2023 | Sell -- (Common Stock) | 3103 | 0.33 | 16984 |
| Nov 8, 2023 | M -- (Common Stock) | 6500 | 0 | 20087 |
| Nov 3, 2023 | Sell -- (Common Stock) | 6854 | 0.33 | 13587 |
| Nov 2, 2023 | M -- (Common Stock) | 12500 | 0 | 20441 |
| Aug 9, 2023 | Sell -- (Common Stock) | 3434 | 9.51 | 7941 |
| Aug 8, 2023 | M -- (Common Stock) | 6500 | 0 | 11375 |
| May 9, 2023 | Sell -- (Common Stock) | 66730 | 0.13 | 97516 |
| May 8, 2023 | M -- (Common Stock) | 130000 | 0 | 164246 |